Bright Minds Biosciences Inc. (DRUG) vs Evolus, Inc. (EOLS)

A side-by-side comparison of Bright Minds Biosciences Inc. and Evolus, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Bright Minds Biosciences Inc. logo
DRUG
Bright Minds Biosciences Inc.
$487M
$49.79HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Evolus, Inc. logo
EOLS
Evolus, Inc.
$492M
$7.47HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — DRUG vs EOLS

growth of $100 · dividends reinvested · last 6y
DRUG +84.4% (+10.7%/yr)EOLS -48.0% (-10.3%/yr)DRUG compounded faster over this window
0100200300Start $10020222023202420252026$184$52
DRUG EOLS

DRUG vs EOLS: by the numbers

  • •EOLS is the larger company ($492M vs $487M market cap).
  • •Both run net losses; DRUG's is the smaller (0.00% vs -10.85% net margin).

Metrics side by side

Valuation

MetricDRUGEOLS
P/S ratioN/A1.55
P/B ratio2.25N/A

Profitability

MetricDRUGEOLS
Gross margin0.00%66.25%
Operating margin0.00%-7.33%
Net margin0.00%-10.85%
ROE-8.21%N/A
ROIC-13.15%-15.54%

Growth (annualized)

MetricDRUGEOLS
Revenue CAGR (5Y)N/A32.82%
Total return CAGR (5Y)6.76%0.46%

Frequently asked

How have DRUG and EOLS total returns compared?
Over the past 5 years, DRUG delivered 6.76% and EOLS delivered 0.46% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DRUG analysisFull EOLS analysisInteractive comparison tool

Dig into the metrics

Bright Minds Biosciences ROEEvolus ROEBright Minds Biosciences operating marginEvolus operating marginBright Minds Biosciences revenue growthEvolus revenue growthBright Minds Biosciences free cash flowEvolus free cash flow

Bright Minds Biosciences & Evolus appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.